New ketamine-type nasal spray can help 30,000 Australians suffering depression
Spravato® (Esketamine) is the first new type of depression medicine to be added to the PBS in 30 years.
Professor Ian Hickie AO, Co-Director of Health and Policy, Brain and Mind Centre, University of Sydney says Spravato targets a different chemical in the brain, than traditional antidepressants.
'Treatment resistant depression is a very important and a very disabling illness in Australia.
About one in seven Australians has a depressive illness, about two thirds of those will respond to commonly available psychological or medical treatments.'
'You will not be able to get this medicine from your GP and take it home and squirt it up your own nose.'
Instead, it will be provided under strict medical supervision.
Twice a week at first, weekly for the next month, and then weekly or fortnightly until depressive symptoms improve.
The treatment will only be given to patients who have not responded adequately to at least two different antidepressants of adequate dose and duration.
Pensioner or concession card holders will pay just $7.70 and general patients will pay $31.60 for each dose of the medicine.
Veteran Garth Camac has been living with treatment resistant depression for 15 years, and untreated depression for 15 before that.
'It is an expensive medication and having it added to the PBS is a great thing.'
During his service in the Australian Army, he was deployed to Iraq twice.
In Malaysia, completing training, five of his men died in a horrific car accident.
Life after war was a battle he couldn't seem to win.
'I've been in a really uncomfortable place where I've had to decide whether or not today is the day to kill myself, or can I go a little bit further.'
'I had no plans to be alive at 50.'
He's now 52.
For the past two years, he's been taking Spravato.
'It's taken me two years to get to where I am now.'
'I enjoy being out in public now, I'm not scanning for danger, I'm not worrying that something will explode.'
If you or someone you know is struggling:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
2 hours ago
- Sky News AU
'Not up for negotiation': Aussies expected to save $200m a year from major cap on PBS-listed scripts despite tariff threats to industry
Millions of Australians are expected to save $200m in vital medication fees as a landmark bill caps the price of Pharmaceutical Benefits Scheme (PBS) prescriptions at just $25, down from $31.60. The bill is set to take effect from January 1, as the Labor government takes the first steps to legislate the bill and Prime Minister Anthony Albanese vows to keep his election pledge on cost of living relief. The changes mean the cost of medicines on the PBS could be significantly reduced by over 20 per cent. Minister for Health, Mark Butler said five million Australians will feel the relief in their pockets. The cost of medicine for pension and concession card holders will remain frozen at $7.70 until the end of 2029. The bill which was announced by Labor during the May election campaign is expected to cost the budget $690m over four years. Mr Albanese said it built on a pledge for cost of living relief. 'This is another example of cost of living relief that helps every Australian,' he said. 'The size of your bank balance shouldn't determine the quality of your healthcare. My government will continue to deliver cost of living relief for all Australians.' Mr Butler added general patients' medicines haven't been this cheap since 2004. 'The Albanese Government has been focused on delivering cheaper medicines for Australians," he said. 'Cheaper medicines are good for the hip pocket and good for your health." The Assistant Health Minister, Emma McBride said the bill was set to pass despite US President Donald Trump's 200 per cent tariff threat on pharmaceutical imports. The US is Australia's biggest pharmaceutical export market and if the tariff is implemented it could cost the Australian economy up to $2.8 billion and force pharmas' to hike up their prices. However, Ms McBride said the PBS is not up for negotiation and "it is not a bargaining chip". "Labor introduced the Pharmaceutical Benefits Scheme to make sure that essential medicines were available to all Australians, and with this introduction of legislation to enact our election commitment, it will mean a cap on $25, which will save Australians about $200 million a year, 5.1 million Australians estimated to benefit," she said.
Sky News AU
3 hours ago
- Sky News AU
Labor's move to reduce PBS prescription cost will save Australians $200 million a year
The Albanese government is set to reduce PBS prescription prices to $25. Health Minister Mark Butler said the move will save five million Australian patients $200 million a year.
West Australian
3 hours ago
- West Australian
Australian news and politics live: Independent MP Chaney to introduce Bill to ban AI child sexual abuse apps
Scroll down for the latest news and updates. Independent MP Kate Chaney will today introduce a bill to outlaw technology that assists in the creation of child sexual abuse material. Under the bill it would be an offence to posess AI tools designed for the sole purpose of creating child sexual abuse material. 'This is a clear gap in our Criminal Code that I think we need to be able to respond quickly on so we can make sure we're keeping kids safe,' she said on ABC. 'Currently, possession of these images is illegal, but it's not illegal to possess these particular types of AI tools that are designed for the sole purpose of creating child sexual abuse material. 'So, it means that perpetrators can generate the material using images of real children, delete the images, and then recreate them whenever they want and avoid detection. 'This bill is focused on making it illegal to download these tools that are designed to create this material.' Ms Chaney said action was needed now. 'The challenge that we have is that we're creating a lot of reports and consultations, and the technology is moving so fast, so I think there's a need for urgent action on this. 'We need to be able to plug the gaps as we go, while addressing the broad issues about how we're going to encourage take-up of AI for its productivity benefits but creating appropriate guardrails so that people can have faith in it.'. Australians will pay no more than $25 for selected medicines for the first time in more than 20 years under a proposal to be brought before parliament. It will be the second cap on medicines on the Pharmaceutical Benefits Scheme (PBS) introduced by the Albanese government in three years, after it cut the maximum price of PBS prescriptions from $42.50 to $30. 'The size of your bank balance shouldn't determine the quality of your health care,' Prime Minister Anthony Albanese said. 'My government will continue to deliver cost-of-living relief for all Australians.' PBS medicines would be capped at $7.70 for pensioners and concession card holders until 2030. The bill's introduction is largely a formality, with its passage through the lower house all but assured thanks to Labor's massive 94-seat majority in the 150-seat House of Representatives. Read the story West is best again in economic circles but big gains made on the other side of the Nullarbor have surprised economists and left eastern states languishing. A boost in housing construction has propelled South Australia to second position, above Queensland and Victoria, in CommSec's latest State of the States report released on Monday. Western Australia remains the nation's top performer for the fourth straight quarter with strong returns on retail spending and business investment, but an upheaval could be on the horizon. 'We are seeing Western Australia lose a little bit of momentum,' CommSec chief economist Ryan Felsman told AAP. 'It's been growing at a breakneck speed the last two or three years, and the reason for that is population growth has been the highest for some time.' Read the story A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. 'This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable',' Mr Butler said in a statement. 'For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient.'
